Skip to main content
Top
Published in: Clinical Rheumatology 11/2017

01-11-2017 | Original Article

Prevalence of musculoskeletal diseases in a semi-urban Nigerian community: results of a cross-sectional survey using COPCORD methodology

Authors: Uhunmwangho U. Courage, Dungwom P. Stephen, Imoh C. Lucius, Charles Ani, Agbaji O. Oche, Agaba I Emmanuel, Adelowo O. Olufemi

Published in: Clinical Rheumatology | Issue 11/2017

Login to get access

Abstract

The International League of Associations for Rheumatology (ILAR) in collaboration with the World Health Organization (WHO) initiated the Community Oriented Program for the Control of Rheumatic diseases (COPCORD) to promote the growth of rheumatology in developing countries. This is the first COPCORD-type survey carried out in a West African community. The objective of this study was to determine the prevalence of musculoskeletal diseases in a semi-urban Nigerian community, using the COPCORD methodology. This is a cross-sectional total population survey, carried out in Katon Rikkos, Jos, Nigeria, from June 2015 to November 2016. All inhabitants of the community who are 15 years and older were included in the study, except those who were not available or refused to participate. Trained health workers from the community carried out a house-to-house survey, to administer the COPCORD questionnaire. People reporting musculoskeletal symptoms were examined and investigated at the teaching hospital, to determine the specific type of musculoskeletal diseases. Data was analyzed using Epi-info version 7.1.5 and P values of <0.05 were considered statistically significant. The median age of the study population was 33 (IQR 24–46) years, with a male to female ratio of 1:1.1. The prevalence of musculoskeletal disease was 33%. Females (57.0%) were more affected than males (43.0%); the most common form of musculoskeletal diseases diagnosed was osteoarthritis (22.0%). Male sex and a family history of musculoskeletal diseases were independent predictors of musculoskeletal diseases. A Health Assessment Questionnaire Disability Index (HAQ-DI) ≥1 was recorded in 14% of subjects with musculoskeletal diseases. The prevalence of musculoskeletal diseases in this community is high with significant disability; therefore, there is urgent need for increased access to rheumatology care in the community.
Literature
1.
go back to reference Chopra A, Abdel-Nasser A (2008) Epidemiology of rheumatic musculoskeletal disorders in the developing world. Best Pract Res ClinRheumatol 22:583–604CrossRef Chopra A, Abdel-Nasser A (2008) Epidemiology of rheumatic musculoskeletal disorders in the developing world. Best Pract Res ClinRheumatol 22:583–604CrossRef
2.
go back to reference World Health Organization Scientific Group on the Burden of Musculoskeletal Conditions at the Start of the New Millennium (2003). The burden of musculoskeletal conditions at the start of the new millennium. World Health Organ Tech Rep Ser. 919:i-x, 1–218. World Health Organization Scientific Group on the Burden of Musculoskeletal Conditions at the Start of the New Millennium (2003). The burden of musculoskeletal conditions at the start of the new millennium. World Health Organ Tech Rep Ser. 919:i-x, 1–218.
3.
go back to reference Al-Awadhi A, Olusi S, Moussa M, Al-Zaid N, Shehab D, Al-Herz A et al (2002) Validation of the Arabic version of the WHO-ILAR COPCORD Core Questionnaire for community screening of rheumatic diseases in Kuwaitis. World Health Organization, International League Against Rheumatism, Community Oriented Program for the Control of Rheumatic Diseases. J Rheumatol 29:1754–1759PubMed Al-Awadhi A, Olusi S, Moussa M, Al-Zaid N, Shehab D, Al-Herz A et al (2002) Validation of the Arabic version of the WHO-ILAR COPCORD Core Questionnaire for community screening of rheumatic diseases in Kuwaitis. World Health Organization, International League Against Rheumatism, Community Oriented Program for the Control of Rheumatic Diseases. J Rheumatol 29:1754–1759PubMed
4.
go back to reference Grabauskas VA (1983) World Health Organization perspective. J Rheumatol Suppl 10:5–6PubMed Grabauskas VA (1983) World Health Organization perspective. J Rheumatol Suppl 10:5–6PubMed
5.
go back to reference Ekwom PE, Oyoo GO, Ongore D (2013). Prevalence of musculoskeletal pain in Nairobi, Kenya: results of a phase 1, stage 1 COPCORD study. Abstracts of the 7th Congress of the African League of Associations for Rheumatology (AFLAR) and the 23rd Congress of the South African Rheumatism and Arthritis Association (SARAA). April 3–6, 2013. Durban, South Africa ClinRheumatol 32 Suppl 2:S121–S152. Ekwom PE, Oyoo GO, Ongore D (2013). Prevalence of musculoskeletal pain in Nairobi, Kenya: results of a phase 1, stage 1 COPCORD study. Abstracts of the 7th Congress of the African League of Associations for Rheumatology (AFLAR) and the 23rd Congress of the South African Rheumatism and Arthritis Association (SARAA). April 3–6, 2013. Durban, South Africa ClinRheumatol 32 Suppl 2:S121–S152.
7.
go back to reference Darmawan J, Ferraz MB, Muirden KD, Tugwell P (1995) Case study: World Health Organization-International League of Associations for Rheumatology Community-Oriented Program for the Control of Rheumatic Diseases (WHO-ILAR COPCORD) in Indonesia and Brazil. Int J Technol Assess Health Care 11:700–708CrossRefPubMed Darmawan J, Ferraz MB, Muirden KD, Tugwell P (1995) Case study: World Health Organization-International League of Associations for Rheumatology Community-Oriented Program for the Control of Rheumatic Diseases (WHO-ILAR COPCORD) in Indonesia and Brazil. Int J Technol Assess Health Care 11:700–708CrossRefPubMed
8.
go back to reference Muirden KD (1997) The origins and evolution of COPCORD APLAR. J Rheumatol 1:44–48 Muirden KD (1997) The origins and evolution of COPCORD APLAR. J Rheumatol 1:44–48
9.
go back to reference Minaur N, Sawyers S, Parker J, Darmawan J (2004) Rheumatic disease in an Australian Aboriginal community in North Queensland. Australia A WHO-ILAR COPCORD survey J Rheumatol 31:965–972PubMed Minaur N, Sawyers S, Parker J, Darmawan J (2004) Rheumatic disease in an Australian Aboriginal community in North Queensland. Australia A WHO-ILAR COPCORD survey J Rheumatol 31:965–972PubMed
10.
go back to reference Haq SA, Darmawan J, Islam MN, Uddin MZ, Das BB, Rahman F et al (2005) Prevalence of rheumatic diseases and associated outcomes in rural and urban communities in Bangladesh: a COPCORD study. J Rheumatol 32:348–353PubMed Haq SA, Darmawan J, Islam MN, Uddin MZ, Das BB, Rahman F et al (2005) Prevalence of rheumatic diseases and associated outcomes in rural and urban communities in Bangladesh: a COPCORD study. J Rheumatol 32:348–353PubMed
11.
go back to reference Ibrahim T (2009). Sample size determination. In: research methodology and dissertation writing for health and allied health professionals. 1st edition. Abuja, Nigeria: Cress global link limited; p.75. Ibrahim T (2009). Sample size determination. In: research methodology and dissertation writing for health and allied health professionals. 1st edition. Abuja, Nigeria: Cress global link limited; p.75.
12.
go back to reference Chaiamnuay P, Darmawan J, Muirden KD, Assawatanabodee P (1998) Epidemiology of rheumatic disease in rural Thailand: a WHO-ILAR COPCORD study. J Rheumatol 25:1382–1387PubMed Chaiamnuay P, Darmawan J, Muirden KD, Assawatanabodee P (1998) Epidemiology of rheumatic disease in rural Thailand: a WHO-ILAR COPCORD study. J Rheumatol 25:1382–1387PubMed
14.
go back to reference Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K et al (1986) The American College of Rheumatology Criteria for the classification and reporting of osteoarthritis of the knee. Arthritis Rheum 29:1039–1049CrossRefPubMed Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K et al (1986) The American College of Rheumatology Criteria for the classification and reporting of osteoarthritis of the knee. Arthritis Rheum 29:1039–1049CrossRefPubMed
15.
go back to reference Altman R, Alarcon G, Appelrout D et al (1991) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 34:505–514CrossRefPubMed Altman R, Alarcon G, Appelrout D et al (1991) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 34:505–514CrossRefPubMed
16.
go back to reference Aletaha D, Neogo T, Silman JA et al (2010) Rheumatoid arthritis classification criteria: an American college of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569-2581CrossRef Aletaha D, Neogo T, Silman JA et al (2010) Rheumatoid arthritis classification criteria: an American college of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569-2581CrossRef
17.
go back to reference Keith P, Karen WB, Cathy L et al (2000) The Southampton examination schedule for the diagnosis of musculoskeletal disorders of the upper limb. Ann Rheum Dis 59:5–11CrossRef Keith P, Karen WB, Cathy L et al (2000) The Southampton examination schedule for the diagnosis of musculoskeletal disorders of the upper limb. Ann Rheum Dis 59:5–11CrossRef
18.
go back to reference Wolfe F, Smythe HA, Yunus MS et al (1990) The American College of Rheumatology1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:100–172CrossRef Wolfe F, Smythe HA, Yunus MS et al (1990) The American College of Rheumatology1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:100–172CrossRef
19.
go back to reference Dalbeth N, Fransen J, Jansen TL, Neogi T, Schumacher HR, Taylor WJ (2013) New classification criteria for gout: a framework for progress. Rheumatology (Oxford) 52:1748–1753CrossRef Dalbeth N, Fransen J, Jansen TL, Neogi T, Schumacher HR, Taylor WJ (2013) New classification criteria for gout: a framework for progress. Rheumatology (Oxford) 52:1748–1753CrossRef
21.
go back to reference Senna ER, De Barros AL, Silva EO, Costa IF, Pereira LV, Ciconelli RM, Ferraz MB (2004) Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol 31:594–597PubMed Senna ER, De Barros AL, Silva EO, Costa IF, Pereira LV, Ciconelli RM, Ferraz MB (2004) Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol 31:594–597PubMed
22.
go back to reference Llerena GAR, Toledani MG, Martinez AAH, Otero ZAG, Varela JA, Gardiel MH (2000) Prevalence of musculoskeletal complaints and disability in Cuba. A community based study using the COPCORD core questionnaire. Clin Exp Rheumatol 18:739–742 Llerena GAR, Toledani MG, Martinez AAH, Otero ZAG, Varela JA, Gardiel MH (2000) Prevalence of musculoskeletal complaints and disability in Cuba. A community based study using the COPCORD core questionnaire. Clin Exp Rheumatol 18:739–742
23.
go back to reference Chou CT, Pei L, Chang DM, Lee CF, Schumacher HR, Liang MH (1994) Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol 21:302–306PubMed Chou CT, Pei L, Chang DM, Lee CF, Schumacher HR, Liang MH (1994) Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol 21:302–306PubMed
24.
go back to reference Pelaez-Ballestas I, Sanin LH, Moreno-Montoya J, Alvarez-Nemegyei J, Burgos-Vargas R et al (2011) Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology. J Rheumatol suppl 86:3–6CrossRefPubMed Pelaez-Ballestas I, Sanin LH, Moreno-Montoya J, Alvarez-Nemegyei J, Burgos-Vargas R et al (2011) Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology. J Rheumatol suppl 86:3–6CrossRefPubMed
25.
go back to reference Fransen PM, Rowland G, Leenars EFK, Esink-Bot ML (2014) Self rated literacy level does not explain educational differences in health and disease. Archives of Public health 72:14CrossRefPubMedPubMedCentral Fransen PM, Rowland G, Leenars EFK, Esink-Bot ML (2014) Self rated literacy level does not explain educational differences in health and disease. Archives of Public health 72:14CrossRefPubMedPubMedCentral
27.
go back to reference Chopra A, Abdel-Nasser A (2008) Epidemiology of rheumatic musculoskeletal disorders in the developing world. Best Pract Res Clin Rheumatol 22:583–604CrossRefPubMed Chopra A, Abdel-Nasser A (2008) Epidemiology of rheumatic musculoskeletal disorders in the developing world. Best Pract Res Clin Rheumatol 22:583–604CrossRefPubMed
29.
go back to reference Obidiya Olatunji SCIEETS, Ilodigwe Emmanuel E (2011) Health seeking behaviour among residents of Yenagoa city, Nigeria. Continental J pharmaceutical sciences 5:14–19 Obidiya Olatunji SCIEETS, Ilodigwe Emmanuel E (2011) Health seeking behaviour among residents of Yenagoa city, Nigeria. Continental J pharmaceutical sciences 5:14–19
Metadata
Title
Prevalence of musculoskeletal diseases in a semi-urban Nigerian community: results of a cross-sectional survey using COPCORD methodology
Authors
Uhunmwangho U. Courage
Dungwom P. Stephen
Imoh C. Lucius
Charles Ani
Agbaji O. Oche
Agaba I Emmanuel
Adelowo O. Olufemi
Publication date
01-11-2017
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 11/2017
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-017-3648-z

Other articles of this Issue 11/2017

Clinical Rheumatology 11/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.